Low-dose rifaximin prevents complications and improves survival in patients with decompensated liver cirrhosis
Low-dose rifaximin prevents complications and improves survival in patients with decompensated liver cirrhosis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Low-dose rifaximin prevents complications and improves survival in patients with decompensated liver cirrhosis have?
Low-dose rifaximin prevents complications and improves survival in patients with decompensated liver cirrhosis has 39 citations in the OpenAlex counts ScholarIQ stores.
When was Low-dose rifaximin prevents complications and improves survival in patients with decompensated liver cirrhosis published?
Low-dose rifaximin prevents complications and improves survival in patients with decompensated liver cirrhosis has 2021 year in the ScholarIQ index.
What is the open-access status of Low-dose rifaximin prevents complications and improves survival in patients with decompensated liver cirrhosis?
Low-dose rifaximin prevents complications and improves survival in patients with decompensated liver cirrhosis has closed oa status in the ScholarIQ index.
What is the DOI of Low-dose rifaximin prevents complications and improves survival in patients with decompensated liver cirrhosis?
The DOI for Low-dose rifaximin prevents complications and improves survival in patients with decompensated liver cirrhosis is on the source record.
What is the PMID of Low-dose rifaximin prevents complications and improves survival in patients with decompensated liver cirrhosis?
The PMID for Low-dose rifaximin prevents complications and improves survival in patients with decompensated liver cirrhosis is on the source record.
What is the OpenAlex record for Low-dose rifaximin prevents complications and improves survival in patients with decompensated liver cirrhosis?
The OpenAlex for Low-dose rifaximin prevents complications and improves survival in patients with decompensated liver cirrhosis is on the source record.